Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1989
Striatal dopamine D2 receptors in tardive dyskinesia: PET study
J Blin, J C Baron, H Cambon, et al.
Neurology
|
June 1, 1989
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test
B Pillon, B Dubois, A M Bonnet, et al.
Lancet (London, England)
|
September 29, 2004
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease
P Ibáñez, A-M Bonnet, B Débarges, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
A M Bonnet, G Tell, P J Schechter, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
June 1, 1979
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease
Y Agid, G Barroche, A M Bonnet, et al.
Annals of Neurology
|
April 1, 1994
Eye movements in parkinsonian syndromes
M Vidailhet, S Rivaud, N Gouider-Khouja, et al.
Neurology
|
December 13, 2000
Improvement of sleep architecture in PD with subthalamic nucleus stimulation
I Arnulf, B P Bejjani, L Garma, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 15, 2000
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation
B P Bejjani, D Gervais, I Arnulf, et al.
Neurology
|
May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
S Descombes, A M Bonnet, U E Gasser, et al.
Neurology
|
December 31, 1997
Pallidal stimulation for Parkinson's disease. Two targets?
B Bejjani, P Damier, I Arnulf, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1989
Striatal dopamine D2 receptors in tardive dyskinesia: PET study
J Blin, J C Baron, H Cambon, et al.
Neurology
|
June 1, 1989
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test
B Pillon, B Dubois, A M Bonnet, et al.
Lancet (London, England)
|
September 29, 2004
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease
P Ibáñez, A-M Bonnet, B Débarges, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
A M Bonnet, G Tell, P J Schechter, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
June 1, 1979
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease
Y Agid, G Barroche, A M Bonnet, et al.
Annals of Neurology
|
April 1, 1994
Eye movements in parkinsonian syndromes
M Vidailhet, S Rivaud, N Gouider-Khouja, et al.
Neurology
|
December 13, 2000
Improvement of sleep architecture in PD with subthalamic nucleus stimulation
I Arnulf, B P Bejjani, L Garma, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 15, 2000
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation
B P Bejjani, D Gervais, I Arnulf, et al.
Neurology
|
May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
S Descombes, A M Bonnet, U E Gasser, et al.
Neurology
|
December 31, 1997
Pallidal stimulation for Parkinson's disease. Two targets?
B Bejjani, P Damier, I Arnulf, et al.
Page
of 10